EW | Edwards Lifesciences

93.02 -0.62 (-0.66%)

EW Price Profile

Open

$91.97

CLOSE

$93.02

DAY RANGE

91.34 - 94.05

52 WEEK RANGE

91.34 - 131.73

MARKET CAP

67.69B

Trading volume

602.07K

Prev. Close

93.64

50 Day MA

118.97

Shares Outstanding

624.33M

Public Float

619.13M

Average Volume

2.24M

Beta

1.09

PEG Ratio

3.34

Shares Shorted

6.08M

% OF SHARES SHORTED

0.98%

Short Ratio

2.31

1 Year Performance

29.05%

Diluted EPS (TTM)

2.33

Q Revenue Growth

0.15

Ebitda

1.72B

Gross Profit (TTM)

3.31B

Total Cash (MRQ)

1.79B

Total Debt (MRQ)

684.1M

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Edwards Lifesciences (EW) company profile

Edwards Lifesciences (NYSE: EW) is an American company that designs, develops, and markets products and services to treat heart-related diseases. It offers transcatheter heart and surgical heart valves, heart valve repair, cardiac cannula, hemodynamic monitoring, pressure monitoring, vascular surgery, and investigational devices. Additionally, it provides surgical heart valve therapy products, including pericardial valves for aortic and mitral surgical valve replacement, aortic heart valves; annuloplasty rings; cardiac cannula devices; a beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation.

Latest EW News

AD